(01:20:59) Females & Male-Type Mounting Behavior (01:24:40) PAG (Periaqueductal Gray) Brain Region: Pain Modulation & Fear (01:30:38) Tachykinins & Social Isolation: Anxiety, Fear & Aggression (01:43:49) Brain, Body & Emotions
Research suggests approximately 6070% of weight loss on GLP-1 therapy comes from reduced calorie intake via appetite suppression, while 3040% results from improved metabolic efficiency and glucose handling
Semaglutide: Which Peptide Is More Effective
However, it also promotes weight loss by reducing appetite and increasing feelings of fullness
Gullaksen S, Vernstrm L, Srensen SS, Funck KL, Petersen L, Bek T et al
Patients with certain GLP1R variants may experience more pronounced nausea during the adjustment phase and benefit from slower titration or additional digestive support